Pharma and Biotech
Year End | Type | Amount | Payment Date | Ex-Div Date | Record Date |
---|---|---|---|---|---|
30-Sep-19 | Interim | 00.00 | |||
Final | 00.00 |
Find out about IFRS and how this affects the financial infomation for all UK companies.
Currency | UK Pounds |
Share Price | 40.00p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 48.00p |
52 Week Low | 34.00p |
Volume | 100,222 |
Shares Issued | 739.78m |
Market Cap | £295.91m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 1 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
15:11 | 5,535 @ 40.00p |
15:11 | 5,307 @ 40.00p |
15:11 | 6,025 @ 40.00p |
15:11 | 5,593 @ 40.00p |
15:10 | 5,000 @ 40.00p |
Chair | Peter George |
CFO | Septima Maguire |
CEO | Trond Williksen |
You are here: research